224 related articles for article (PubMed ID: 27123695)
41. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics and ADME Characterization of Intravenous and Oral [
Zamek-Gliszczynski MJ; Kenworthy D; Bershas DA; Sanghvi M; Pereira AI; Mudunuru J; Crossman L; Pirhalla JL; Thorpe KM; Dennison JMTJ; McLaughlin MM; Allinder M; Swift B; O'Connor-Semmes RL; Young GC
Drug Metab Dispos; 2021 Dec; 49(12):1109-1117. PubMed ID: 34625435
[TBL] [Abstract][Full Text] [Related]
43. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
44. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
[TBL] [Abstract][Full Text] [Related]
45. Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy Subjects.
Holmberg AA; Weidolf L; Necander S; Bold P; Sidhu S; Pelay-Gimeno M; de Ligt RAF; Verheij ER; Jauhiainen A; Psallidas I; Wählby Hamrén U; Prothon S
Drug Metab Dispos; 2022 Feb; 50(2):150-157. PubMed ID: 34853068
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Causes of the Ultra-Low Oral Bioavailability and Metabolic Pathway.
Li P; Peng J; Li Y; Gong L; Lv Y; Liu H; Zhang T; Yang S; Liu H; Li J; Liu L
Front Pharmacol; 2021; 12():621003. PubMed ID: 33935711
[No Abstract] [Full Text] [Related]
47. A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [
Pápai Z; Chen LC; Da Costa D; Blotner S; Vazvaei F; Gleave M; Jones R; Zhi J
Cancer Chemother Pharmacol; 2019 Jul; 84(1):93-103. PubMed ID: 31062077
[TBL] [Abstract][Full Text] [Related]
48. Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study.
Suri A; Pusalkar S; Li Y; Prakash S
Clin Pharmacol Drug Dev; 2016 May; 5(3):180-7. PubMed ID: 27163496
[TBL] [Abstract][Full Text] [Related]
49. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
[TBL] [Abstract][Full Text] [Related]
50. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
51. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
Möller A; Iwasaki K; Kawamura A; Teramura Y; Shiraga T; Hata T; Schäfer A; Undre NA
Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
[TBL] [Abstract][Full Text] [Related]
52. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
[TBL] [Abstract][Full Text] [Related]
53. Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.
Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Brian Houston J; Oosterhuis B; Bjerrum OJ; Grynkiewicz G; Alder J; Rowland M; Garner C
Eur J Pharm Sci; 2011 Jun; 43(3):141-50. PubMed ID: 21540108
[TBL] [Abstract][Full Text] [Related]
54. Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects.
Lindmark B; Li XQ; Bhattacharya C; Housler G; Heijer M; Bragg RA; Gränfors M; Pelay-Gimeno M; Vaes WHJ; Menakuru S; Pizzato PE; Ericsson H; Johansson S
Drug Metab Dispos; 2023 Aug; 51(8):995-1004. PubMed ID: 37407094
[TBL] [Abstract][Full Text] [Related]
55. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
Vyas KP; Halpin RA; Geer LA; Ellis JD; Liu L; Cheng H; Chavez-Eng C; Matuszewski BK; Varga SL; Guiblin AR; Rogers JD
Drug Metab Dispos; 2000 Jan; 28(1):89-95. PubMed ID: 10611145
[TBL] [Abstract][Full Text] [Related]
56. A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteers.
Bello CL; Smith E; Ruiz-Garcia A; Ni G; Alvey C; Loi CM
Cancer Chemother Pharmacol; 2013 Aug; 72(2):379-85. PubMed ID: 23760812
[TBL] [Abstract][Full Text] [Related]
57. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
58. Metabolism and disposition of moxonidine in Fischer 344 rats.
He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
[TBL] [Abstract][Full Text] [Related]
59. Absolute bioavailability of imidafenacin after oral administration to healthy subjects.
Ohno T; Nakade S; Nakayama K; Kitagawa J; Ueda S; Miyabe H; Masuda Y; Miyata Y
Br J Clin Pharmacol; 2008 Feb; 65(2):197-202. PubMed ID: 18251758
[TBL] [Abstract][Full Text] [Related]
60. Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5.
Fuxe K; Borroto-Escuela DO
Expert Opin Investig Drugs; 2015; 24(9):1247-60. PubMed ID: 26219727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
